Global Immunoglobulin (IG) Usage in 2023 & Forecast to 2030

 

 AN ANALYSIS OF THE GLOBAL IMMUNOGLOBULIN (IG) MARKET IN 2023
AND FORECAST TO THE YEAR 2030 by country

As immunoglobulin (IG) is the dominant revenue-generating therapeutic protein from plasma fractionation, its future growth rate profoundly impacts the entire industry on a number of levels, including plasma collections planning, manufacturing infrastructure planning, projection of per-liter plasma valuation, and revenue and profit forecasting.  For these and other reasons, projection of the likely future demand for IG is of critical importance in the plasma industry.

This new report takes a deep look at current IG usage levels around the globe, and details how IG is used by medical specialty and key indications across all five geographic regions (North America, South America, Asia/Pacific, Europe, and the Middle East/Africa). Extra attention is spent on the United States market, the largest and most valuable IG market in the world. MRB’s forecast model analyzes both key drivers of IG growth and risks to future growth, taking into account how the interaction of plasma supply and IG demand can be expected to influence price patterns globally over the next 7 years. This report identifies IG usage in over  100 countries in 2023, including breakdowns of IVIG and SCIG market shares by geographic region.  For 2024 through 2030, the report forecasts country-level IG product sales in units and US dollars and average ex-manufacturer price per gram.  Also detailed for each region are key growth drivers and expected growth rates by region over the forecast period. The relative growth rates and drivers of SCIG vs. IVIG are also addressed on a regional basis, as are the usage by medical specialty.

Today, there is novel competition to IG usage in the form of anti-FcRn products in several autoimmune conditions including Myasthenia Gravis, ITP and CIDP. The future impact of these therapies (and others) is important to fully grasp, as any effect on IG sales or pricing affects the entire plasma industry significantly. Based on many discussions with KOL physician experts and a survey of industry’s thinking on this competition, an in-depth explanation of the likely impact is detailed in the report.

Contact us at info@marketingresearchbureau.com for pricing or to order the report. 

 

TABLE OF CONTENTS OF PRESENT REPORT

EXECUTIVE SUMMARY   (Pages 5-16)

 

1. INTRODUCTION   (Pages 17-19)

2. FORECAST ASSUMPTIONS   (Pages 20-25)

3. NORTH AMERICA IMMUNOGLOBULIN USAGE & FORECAST   (Pages 26-57)

2023 IG Usage in North America
Current IG Usage by Indication in the United States
   Neurological IG Usage in the United States
   Primary & Secondary Immunodeficiency IG Usage in the United States
Canada Current IG Usage by Indication
Forecast to 2030 in North America
   Growth Drivers of IG Usage over Forecast Period

4. EUROPE IMMUNOGLOBULIN USAGE & FORECAST   (Pages 58-100)

2023 IG Usage in Europe
United Kingdom Current IG Usage by Indication
France Current IG Usage by Indication
Belgium Current IG Usage by Indication
Neurological Immunoglobulin Usage in Europe
Primary Immunodeficiency and Immunoglobulin Usage in Europe
Secondary Immunodeficiency and Immunoglobulin Usage in Europe
Forecast to 2030 in Europe
   Growth Drivers of IG Usage over the Forecast Period

5. ASIA & PACIFIC IMMUNOGLOBULIN USAGE & FORECAST   (Pages 101-136)

2023 IG Usage in Asia Pacific
Australia Current IG Usage by Indication

New Zealand Current IG Usage by Indication

Chinese IG Analysis

Hong Kong IG Usage
Primary & Secondary Immunodeficiency and Immunoglobulin Usage in Asia Pacific
Neurological and Other Immunoglobulin Usage in Asia Pacific
Forecast to 2030 in Asia Pacific
   Growth Drivers of IG Usage over Forecast Period

6. THE MIDDLE EAST & AFRICA IMMUNOGLOBULIN USAGE & FORECAST   (Pages 137-159)

2023 IG Usage in Middle East & Africa
Primary Immunodeficiency and Immunoglobulin Usage in Africa
Other Immunoglobulin Usage in Latin America
Forecast to 2030 in Middle East & Africa
   Growth Drivers of IG Usage over Forecast Period

7. LATIN AMERICA IMMUNOGLOBULIN USAGE & FORECAST   (Pages 160-184)

2023 IG Usage in Latin America
Primary & Secondary Immunodeficiency and IG Usage in Latin America
Neurological Immunoglobulin Usage in Latin America
Forecast to 2030 in Latin America
   Growth Drivers of IG Usage over Forecast Period

8. FORECAST OF THE WORLDWIDE IMMUNOGLOBULIN DEMAND   (Pages 185-198)

2023 Global IG Usage
Global IG Forecast from 2023 to 2030

   IVIG vs. SCIG Growth by Region
   IG Growth Expectations by Specialties/Diseases